tiprankstipranks
Trending News
More News >
Oric Pharmaceuticals (ORIC)
NASDAQ:ORIC
Advertisement

Oric Pharmaceuticals (ORIC) Stock Statistics & Valuation Metrics

Compare
366 Followers

Total Valuation

Oric Pharmaceuticals has a market cap or net worth of $938.32M. The enterprise value is $886.43M.
Market Cap$938.32M
Enterprise Value$886.43M

Share Statistics

Oric Pharmaceuticals has 85,224,190 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding85,224,190
Owned by Insiders6.55%
Owned by Institutions0.10%

Financial Efficiency

Oric Pharmaceuticals’s return on equity (ROE) is -0.53 and return on invested capital (ROIC) is -57.32%.
Return on Equity (ROE)-0.53
Return on Assets (ROA)-0.47
Return on Invested Capital (ROIC)-57.32%
Return on Capital Employed (ROCE)-0.57
Revenue Per Employee0.00
Profits Per Employee-1.05M
Employee Count122
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio
PS Ratio0.00
PB Ratio3.51
Price to Fair Value2.31
Price to FCF-7.99
Price to Operating Cash Flow-6.71
PEG Ratio2.12

Income Statement

In the last 12 months, Oric Pharmaceuticals had revenue of 0.00 and earned -127.85M in profits. Earnings per share was -1.83.
Revenue0.00
Gross Profit0.00
Operating Income-142.90M
Pretax Income-127.85M
Net Income-127.85M
EBITDA-126.74M
Earnings Per Share (EPS)-1.83

Cash Flow

In the last 12 months, operating cash flow was -115.01M and capital expenditures -970.00K, giving a free cash flow of -115.98M billion.
Operating Cash Flow-115.01M
Free Cash Flow-115.98M
Free Cash Flow per Share-1.36

Dividends & Yields

Oric Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.60
52-Week Price Change-1.78%
50-Day Moving Average8.72
200-Day Moving Average8.40
Relative Strength Index (RSI)63.38
Average Volume (3m)867.96K

Important Dates

Oric Pharmaceuticals upcoming earnings date is Aug 7, 2025, After Close (Confirmed).
Last Earnings DateMay 5, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend Date

Financial Position

Oric Pharmaceuticals as a current ratio of 10.56, with Debt / Equity ratio of 0.00%
Current Ratio10.56
Quick Ratio10.56
Debt to Market Cap0.00
Net Debt to EBITDA0.44
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Oric Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Oric Pharmaceuticals EV to EBITDA ratio is -4.00, with an EV/FCF ratio of -4.45.
EV to Sales0.00
EV to EBITDA-4.00
EV to Free Cash Flow-4.45
EV to Operating Cash Flow-4.50

Balance Sheet

Oric Pharmaceuticals has $203.72M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$203.72M billion.
Cash & Marketable Securities$203.72M
Total Debt$0.00
Net Cash-$203.72M
Net Cash Per Share-$2.39
Tangible Book Value Per Share$3.49

Margins

Gross margin is 48.97%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin48.97%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Oric Pharmaceuticals is $18.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$18.00
Price Target Upside62.75% Upside
Analyst ConsensusStrong Buy
Analyst Count9
Revenue Growth Forecast
EPS Growth Forecast7.15%

Scores

Smart Score10
AI Score42.65
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis